Higher-than-expected Severe (Grade 3-4) late urinary toxicity after postprostatectomy hypofractionated radiotherapy: A single-institution analysis of 1176 patients

European Urology

Volumn 66, Issue 6, 2014, Pages 1024-1030

  Cozzarini, Cesare ^a   Fiorino, Claudio ^a   Deantoni, Chiara ^a   Briganti, Alberto ^a   Fodor, Andrei ^a   La Macchia, Mariangela ^a   Noris Chiorda, Barbara ^a   Rancoita, Paola Maria Vittoria ^b   Suardi, Nazareno ^a   Zerbetto, Flavia ^a   Calandrino, Riccardo ^a   Montorsi, Francesco ^a   Di Muzio, Nadia ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Dose escalation; Hormonal therapy; Hypertension; Hypofractionation; Late effects; Prostate cancer; Prostatectomy; Radiotherapy; Urinary toxicity; Whole pelvis

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FOLLOW UP; HUMAN; HYPOFRACTIONATED RADIOTHERAPY; INTENSITY MODULATED RADIATION THERAPY; LATE URINARY TOXICITY; MAJOR CLINICAL STUDY; POSTOPERATIVE PERIOD; PROPORTIONAL HAZARDS MODEL; PROSTATECTOMY; RADIOTHERAPY; RETROSPECTIVE STUDY; RISK FACTOR; THREE DIMENSIONAL CONFORMAL RADIOTHERAPY; TOMOTHERAPY; TOXICITY; UROGENITAL TRACT DISEASE; ADJUVANT THERAPY; ADVERSE EFFECTS; BLADDER; COMPLICATION; HEMATURIA; HYPERTENSION; MALE; MIDDLE AGED; PROCEDURES; PROSTATIC NEOPLASMS; RADIATION DOSE FRACTIONATION; RADIATION INJURIES; RADIATION RESPONSE; SALVAGE THERAPY; SEVERITY OF ILLNESS INDEX; TIME; URETHRA; URETHRAL STRICTURE; URINARY BLADDER NECK OBSTRUCTION; URINARY INCONTINENCE; UROLOGIC DISEASES;

AGED; DOSE FRACTIONATION; FOLLOW-UP STUDIES; HEMATURIA; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; SALVAGE THERAPY; SEVERITY OF ILLNESS INDEX; TIME FACTORS; URETHRA; URETHRAL STRICTURE; URINARY BLADDER; URINARY BLADDER NECK OBSTRUCTION; URINARY INCONTINENCE; UROLOGIC DISEASES;

EID: 84909972252     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2014.06.012     Document Type: Article

References (30)

1. G.W. Wong, K.L. Palazzi-Churas, and D.F. Jarrard Salvage hypofractionated radiotherapy for biochemically recurrent prostate cancer after radical prostatectomy Int J Radiat Oncol Biol Phys 70 2008 449 455
2. C. Cozzarini, C. Fiorino, and N. Di Muzio Hypofractionated adjuvant radiotherapy with helical TomoTherapy after radical prostatectomy: planning data and toxicity results of a phase I-II study Radiother Oncol 88 2008 26 33
3. T.J. Kruser, D.F. Jarrard, and A.K. Graf Early hypofractionated salvage radiotherapy for postprostatectomy biochemical recurrence Cancer 117 2011 2629 2636
4. C.R. King, and D.S. Kapp Radiotherapy after prostatectomy: is the evidence for dose escalation out there? Int J Radiat Oncol Biol Phys 71 2008 346 350
5. J.R.J. Bernard, S.J. Buskirk, and M.G. Heckman Salvage radiotherapy for rising prostate-specific antigen levels after radical prostatectomy for prostate cancer: dose-response analysis Int J Radiat Oncol Biol Phys 76 2010 735 740
6. C. Cozzarini, F. Montorsi, and C. Fiorino Need for high radiation dose (>70 Gy) in early postoperative irradiation after radical prostatectomy: a single-institution analysis of 334 high-risk, node-negative patients Int J Radiat Oncol Biol Phys 75 2009 966 974
7. W.R. Lee Prostate cancer and the hypofractionation hypothesis J Clin Oncol 31 2013 3849 3851
8. P. Ost, V. Fonteyne, G. Villeirs, N. Lumen, W. Oosterlinck, and G. De Meerleer Adjuvant high-dose intensity-modulated radiotherapy after radical prostatectomy for prostate cancer: clinical results in 104 patients Eur Urol 56 2009 669 677
9. C.R. King The timing of salvage radiotherapy after radical prostatectomy: a systematic review Int J Radiat Oncol Biol Phys 84 2012 104 111
10. C.R. King, and M.T. Spiotto Improved outcomes with higher doses for salvage radiotherapy after prostatectomy Int J Radiat Oncol Biol Phys 71 2008 23 27
11. I. Syndikus, T. Pickles, E. Kostashuk, and L.D. Sullivan Postoperative radiotherapy for stage pT3 carcinoma of the prostate: improved local control J Urol 155 1996 1983 1986
12. L.W. Lee, C.A. McBain, R. Swindell, J.P. Wylie, R.A. Cowan, and J.P. Logue Hypofractionated radiotherapy as salvage for rising prostate-specific antigen after radical prostatectomy Clin Oncol (R Coll Radiol) 16 2004 517 522
13. J.F. Fowler The radiobiology of prostate cancer including new aspects of fractionated radiotherapy Acta Oncol 44 2005 265 276
14. N. Di Muzio, C. Fiorino, and C. Cozzarini Phase I-II study of hypofractionated simultaneous integrated boost with TomoTherapy for prostate cancer Int J Radiat Oncol Biol Phys 74 2009 392 398
15. C. Cozzarini, C. Fiorino, and G.L. Ceresoli Significant correlation between rectal DVH and late bleeding in patients treated after radical prostatectomy with conformal or conventional radiotherapy (66.6-70.2 Gy) Int J Radiat Oncol Biol Phys 55 2012 688 694
16. C. Cozzarini, C. Fiorino, and N. Di Muzio Significant reduction of acute toxicity following pelvic irradiation with helical TomoTherapy in patients with localized prostate cancer Radiother Oncol 84 2007 164 170
17. C. Fiorino, F. Alongi, and S. Broggi Physics aspects of prostate TomoTherapy: planning optimization and image-guidance issues Acta Oncol 47 2008 1309 1316
18. T.E. Schultheiss, W.R. Lee, M.A. Hunt, A.L. Hanlon, R.S. Peter, and G.E. Hanks Late GI and GU complications in the treatment of prostate cancer Int J Radiat Oncol Biol Phys 37 1997 3 11
19. H. Lukka, C. Hayter, and J.A. Julian Randomized trial comparing two fractionation schedules for patients with localized prostate cancer J Clin Oncol 23 2005 6132 6138
20. J.M. Martin, T. Rosewall, and A. Bayley Phase II trial of hypofractionated image-guided intensity-modulated radiotherapy for localized prostate adenocarcinoma Int J Radiat Oncol Biol Phys 69 2007 1084 1089
21. B.L. Madsen, R.A. Hsi, H.T. Pham, J.F. Fowler, L. Esagui, and J. Corman Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5 Gy in five fractions for localized disease: first clinical trial results Int J Radiat Oncol Biol Phys 67 2007 1099 1105
22. P.A. Kupelian, T.R. Willoughby, C.A. Reddy, E.A. Klein, and A. Mahadevan Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Cleveland Clinic experience Int J Radiat Oncol Biol Phys 68 2007 1424 1430
23. M. Yassa, B. Fortin, M.A. Fortin, C. Lambert, T. Van Nguyen, and J.P. Bahary Combined hypofractionated radiation and hormone therapy for the treatment of intermediate-risk prostate cancer Int J Radiat Oncol Biol Phys 71 2008 58 63
24. E.E. Yeoh, R.J. Botten, J. Butters, A.C. Di Matteo, R.H. Holloway, and J. Fowler Hypofractionated versus conventionally fractionated radiotherapy for prostate carcinoma: final results of phase III randomized trial Int J Radiat Oncol Biol Phys 81 2011 1271 1278
25. M. Lock, L. Best, and E. Wong A Phase II trial of arc-based hypofractionated intensity-modulated radiotherapy in localized prostate cancer Int J Radiat Oncol Biol Phys 80 2011 1306 1315
26. T. Zilli, S. Jorcano, and M. Rouzaud Twice-weekly hypofractionated intensity-modulated radiotherapy for localized prostate cancer with low-risk nodal involvement: toxicity and outcome from a dose escalation pilot study Int J Radiat Oncol Biol Phys 81 2011 382 389
27. V. Fonteyne, G. Soete, and S. Arcangeli Hypofractionated high-dose radiation therapy for prostate cancer: long-term results of a multi-institutional phase II trial Int J Radiat Oncol Biol Phys 84 2012 483 490
28. A. Pollack, G. Walker, and E.M. Horwitz Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer J Clin Oncol 31 2013 3860 3868
29. J.M. Michalski, Y. Yan, and D. Watkins-Bruner Preliminary toxicity analysis of 3-dimensional conformal radiation therapy versus intensity modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group 0126 prostate cancer trial Int J Radiat Oncol Biol Phys 87 2013 932 938
30. C. Cozzarini, C. Fiorino, and L.F. Da Pozzo Clinical factors predicting late severe urinary toxicity after postoperative radiotherapy for prostate carcinoma: a single-institute analysis of 742 patients Int J Radiat Oncol Biol Phys 82 2012 191 199